Which closed-end funds own Cytokinetics Inc?
8 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $33.7M. Security type: common equity. Country: United States. CUSIP 23282W605 · ISIN US23282W6057 · ticker CYTK.
Holdings are historical filings (report dates Jun 30, 2026 – Jul 31, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| BMEZ BlackRock Health Sciences Term Trust | Healthcare | 1.28% | $13.8M | 162,568 sh | $1.1B | NAV unavailable | Jun 30, 2026 |
| BME BlackRock Health Sciences Trust | Healthcare | 0.88% | $5.1M | 59,440 sh | $573M | 3.7% discount | Jun 30, 2026 |
| HQL abrdn Life Sciences Investors | Healthcare | 0.71% | $4.9M | 57,613 sh | $690M | 3.5% discount | Jun 30, 2026 |
| HQH abrdn Healthcare Investors | Healthcare | 0.39% | $5.3M | 61,822 sh | $1.4B | 7.5% discount | Jun 30, 2026 |
| RVT Royce Small-Cap Trust | U.S. Equity | 0.18% | $4.6M | 54,431 sh | $2.6B | 14.0% discount | Jun 30, 2026 |
| GRX Gabelli Healthcare & WellnessRx Trust | Healthcare | 0.11% | $256K | 3,000 sh | $228M | NAV unavailable | Jun 30, 2026 |
| GAB Gabelli Equity Trust | U.S. Equity | 0.00% | $42.6K | 500 sh | $2.4B | 6.5% discount | Jun 30, 2026 |
| CPZ Calamos Long/Short Equity & Dynamic Income Trust | U.S. Equity | -0.12% | $-311K | -4,037 sh | $259M | 15.9% discount | Jul 31, 2026 |
8 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: CYTOKINETICS INC.
Related securities from the same issuer
| Security | Type | Funds holding |
|---|---|---|
| Cytokinetics Inc | debt security | 7 |
Issuer-level search for “CYTK” → · Compare two funds’ portfolios →